Cargando…

Changes in glycemic control and skeletal muscle mass indices after dapagliflozin treatment in individuals with type 1 diabetes mellitus

AIMS/INTRODUCTION: Dapagliflozin is used for individuals with type 1 diabetes, although the effect of this medication on skeletal muscle mass is not well established. In addition, there are few studies examining the effects of good glycemic control on skeletal muscle mass in type 1 diabetes patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshimura, Yuta, Hashimoto, Yoshitaka, Okada, Hiroshi, Takegami, Maya, Nakajima, Hanako, Miyoshi, Tomoki, Yoshimura, Takashi, Yamazaki, Masahiro, Hamaguchi, Masahide, Fukui, Michiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512910/ https://www.ncbi.nlm.nih.gov/pubmed/37424302 http://dx.doi.org/10.1111/jdi.14054

Ejemplares similares

Insulin dose reduction in dapagliflozin combination therapy for type 1 diabetes mellitus: the RISING-STAR study
por: Hamaguchi, Masahide, et al.
Publicado: (2022)

Effect of matcha consumption on gut microbiota in healthy Japanese individuals: study protocol for a double-blind crossover interventional study
por: Takegami, Maya, et al.
Publicado: (2022)

Effect of probiotics, Bifidobacterium bifidum G9-1, on gastrointestinal symptoms in patients with type 2 diabetes mellitus: study protocol for open-label, single-arm, exploratory research trial (Big STAR study)
por: Hashimoto, Yoshitaka, et al.
Publicado: (2020)

Effects of probiotic Bifidobacterium bifidum G9‐1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open‐label, single‐arm, exploratory research trial
por: Hata, Shinnosuke, et al.
Publicado: (2021)

Correlation between Liver Stiffness by Two-Dimensional Shear Wave Elastography and Waist Circumference in Japanese Local Citizens with Abdominal Obesity
por: Miyoshi, Tomoki, et al.
Publicado: (2021)

The effect of COVID-19 pandemic on the lifestyle and glycemic control in patients with type 1 diabetes: a retrospective cohort study
por: Hosomi, Yukako, et al.
Publicado: (2021)

Impact of extracellular‐to‐intracellular fluid volume ratio on albuminuria in patients with type 2 diabetes: A cross‐sectional and longitudinal cohort study
por: Nakajima, Hanako, et al.
Publicado: (2020)

Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study
por: Yoshimura, Yuta, et al.
Publicado: (2021)

Inulin reduces visceral adipose tissue mass and improves glucose tolerance through altering gut metabolites
por: Nakajima, Hanako, et al.
Publicado: (2022)

Habitual Dietary Intake Affects the Altered Pattern of Gut Microbiome by Acarbose in Patients with Type 2 Diabetes
por: Takewaki, Fumie, et al.
Publicado: (2021)

Japanese radio calisthenics prevents the reduction of skeletal muscle mass volume in people with type 2 diabetes
por: Kimura, Tomonori, et al.
Publicado: (2020)

Low circulating arachidonic acid is associated with macroalbuminuria in diabetic patients: a cross-sectional examination of the KAMOGAWA-DM cohort study
por: Okamura, Takuro, et al.
Publicado: (2021)

Microbe‐associated metabolites as targets for incident type 2 diabetes
por: Hashimoto, Yoshitaka, et al.
Publicado: (2020)

Fermented soybean foods and diabetes
por: Hashimoto, Yoshitaka, et al.
Publicado: (2023)

Multicenter, Open-Label, 2-Arm, Pilot Trial for Safe Reduction of Basal Insulin Dose Combined with SGLT2 Inhibitor in Type 1 Diabetes Mellitus: Study Protocol for a RISING-STAR Trial
por: Hamaguchi, Masahide, et al.
Publicado: (2021)

Association between the frequency of toothbrushing and lifestyle in people with type 2 diabetes mellitus: at the baseline date of the Kamogawa-DM cohort study
por: Saijo, Yuto, et al.
Publicado: (2021)

Reduction of Fat to Muscle Mass Ratio Is Associated with Improvement of Liver Stiffness in Diabetic Patients with Non-Alcoholic Fatty Liver Disease
por: Osaka, Takafumi, et al.
Publicado: (2019)

Leucine and Glutamic Acid as a Biomarker of Sarcopenic Risk in Japanese People with Type 2 Diabetes
por: Nakajima, Hanako, et al.
Publicado: (2023)

Frequent Usage of Convenience Stores is Associated with Low Diet Quality
por: Kaji, Ayumi, et al.
Publicado: (2019)

Handgrip measurement as a useful benchmark for locomotive syndrome in patients with type 2 diabetes mellitus: A KAMOGAWA‐DM cohort study
por: Kitagawa, Noriyuki, et al.
Publicado: (2020)

The Effects of Metformin on the Gut Microbiota of Patients with Type 2 Diabetes: A Two-Center, Quasi-Experimental Study
por: Nakajima, Hanako, et al.
Publicado: (2020)

Group 3 Innate Lymphoid Cells Protect Steatohepatitis From High-Fat Diet Induced Toxicity
por: Hamaguchi, Masahide, et al.
Publicado: (2021)

Relative low muscle mass and muscle strength is associated with the prevalence of metabolic syndrome in patients with type 2 diabetes
por: Takegami, Maya, et al.
Publicado: (2022)

Gut Microbiota Changes by an SGLT2 Inhibitor, Luseogliflozin, Alters Metabolites Compared with Those in a Low Carbohydrate Diet in db/db Mice
por: Hata, Shinnosuke, et al.
Publicado: (2022)

Effect of Exercise Habit on Skeletal Muscle Mass Varies with Protein Intake in Elderly Patients with Type 2 Diabetes: A Retrospective Cohort Study
por: Hashimoto, Yoshitaka, et al.
Publicado: (2020)

Effect of COVID-19 Pandemic on the Change in Skeletal Muscle Mass in Older Patients with Type 2 Diabetes: A Retrospective Cohort Study
por: Hasegawa, Yuka, et al.
Publicado: (2021)

Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db/db mice
por: Bamba, Ryo, et al.
Publicado: (2021)

Impact of sustained hypertension on new cardiovascular events in patients with type 2 diabetes: KAMOGAWA‐HBP study
por: Yoshimura, Takashi, et al.
Publicado: (2022)

Habitual Miso (Fermented Soybean Paste) Consumption Is Associated with Glycemic Variability in Patients with Type 2 Diabetes: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2021)

Let-7e-5p Regulates IGF2BP2, and Induces Muscle Atrophy
por: Okamura, Takuro, et al.
Publicado: (2021)

Understanding of antidiabetic medication is associated with blood glucose in patients with type 2 diabetes: At baseline date of the KAMOGAWA‐DM cohort study
por: Sakai, Ryosuke, et al.
Publicado: (2018)

Home-Measured Blood Pressure Is Associated with Handgrip Strength in Patients with Type 2 Diabetes: The KAMOGAWA-HBP Study
por: Kimura, Tomonori, et al.
Publicado: (2021)

Brazilian green propolis improves gut microbiota dysbiosis and protects against sarcopenic obesity
por: Okamura, Takuro, et al.
Publicado: (2022)

Sarcopenia Is Associated With a Risk of Mortality in People With Type 2 Diabetes Mellitus
por: Takahashi, Fuyuko, et al.
Publicado: (2021)

Asymptomatic postprandial hypotension in patients with diabetes: The KAMOGAWA‐HBP study
por: Kitae, Aya, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease with obesity as an independent predictor for incident gastric and colorectal cancer: a population-based longitudinal study
por: Hamaguchi, Masahide, et al.
Publicado: (2019)

Impact of metabolically healthy obesity on the risk of incident gastric cancer: a population-based cohort study
por: Hashimoto, Yoshitaka, et al.
Publicado: (2020)

Comparison of diet, sleep, and stress during the emergency coronavirus disease curfew in men and women with hemodialysis
por: Kawate, Yuka, et al.
Publicado: (2023)

Favorable Appendicular Skeletal Muscle Mass Changes in Older Patients With Type 2 Diabetes Receiving GLP-1 Receptor Agonist and Basal Insulin Co-Therapy
por: Osaka, Takafumi, et al.
Publicado: (2023)

Association between Geriatric Nutrition Risk Index and The Presence of Sarcopenia in People with Type 2 Diabetes Mellitus: A Cross-Sectional Study
por: Takahashi, Fuyuko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n70b7k5cmv43gtb627bsmbkfqr